Your fact-checks will appear here
The use of ivermectin to treat parasitic infections in humans
Ivermectin is FDA‑approved for specific antiparasitic and dermatologic uses in humans — primarily oral formulations for certain parasitic worm infections and topical formulations for skin conditions —...
in clinical practice is weight‑based and usually expressed as micrograms per kilogram (commonly 150–200 mcg/kg for parasitic infections), then converted to milligrams and matched to available tablet s...
Ivermectin in 2025 is a well-established antiparasitic medicine with specific, approved human indications and weight‑based dosing regimens; it is not approved for COVID‑19 or cancer and can be dangero...